BIOMAT Database Logo BIOMAT Database Logo

Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. 1994

T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Merck Research Laboratories, West Point, Pennsylvania 19486.

As part of an ongoing effort to prepare novel non-nucleoside inhibitors of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT), a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin -2(1H)-ones 4aa-l has been prepared. Target compounds 4a-e were synthesized via addition of various 1-lithio-2-(aryl)alkyne nucleophiles to a 1-protected-4-cyclopropylquinazolin-2(1H)-one (7), followed by deprotection. The 3-methyl compound 4aa was prepared in an analogous manner, with the 3-alkylation performed prior to deprotection. Alternatively, the target compounds 4f-l were prepared by addition of 1-lithio-2-(trimethylsilyl)acetylene to 7, followed by deprotection and subsequent palladium-catalyzed coupling with various aryl halides. By incorporating an aryl group onto the end of the 4-acetylene functionality, the requirement for a metabolically labile 3-methyl group on the dihydroquinazolinone nucleus has been eliminated. A number of the target compounds were shown to be potent inhibitors of HIV-1 RT. Compound 4a, which had exhibited the most favorable overall biological profile, was resolved via a four-step procedure to provide the enantiomers 13a and 13b. Compound 13a having the (-)-4(S) configuration was shown to be the active enantiomer and was selected as a candidate for further investigation.

UI MeSH Term Description Entries
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase.
October 2019, Molecules (Basel, Switzerland),
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
June 2014, Bioorganic & medicinal chemistry,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
June 2012, ACS medicinal chemistry letters,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2007, ChemMedChem,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
April 2007, Journal of medicinal chemistry,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors.
September 2016, Chemical biology & drug design,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
July 2011, Bioorganic & medicinal chemistry,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series.
June 1998, Bioorganic & medicinal chemistry letters,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
April 2008, Bioorganic & medicinal chemistry,
T J Tucker, and T A Lyle, and C M Wiscount, and S F Britcher, and S D Young, and W M Sanders, and W C Lumma, and M E Goldman, and J A O'Brien, and R G Ball
Synthesis of 2-methylsulfanyl-1H-imidazoles as novel non-nucleoside reverse transcriptase inhibitors (NNRTIs).
June 2003, Archiv der Pharmazie,
Copied contents to your clipboard!